SSupernus Pharmaceuticals develops and commercializes medications for CNS diseases. It is fully integrated, handling R&D, manufacturing, and commercialization, and earns revenue from product sales and licensing; US sales target neurologists and psychiatrists with a specialty sales force, while international markets rely on partnerships. The company uses proprietary drug-delivery technologies—Microtrol, Solutrol, and EnSoTrol—to create extended-release formulations. Its portfolio includes Qelbree, Gocovri, Oxtellar XR, Trokendi XR, and ZURZUVAE from Sage Therapeutics, with growth driven by acquisitions and collaborations.
Work here?Claim your company
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
501-1,000
Company Stage
IPO
Headquarters
Rockville, MD
Founded
2005
See people who can refer or advise you
Total Funding
$679.5M
Above
Industry Average
Funded Over
6 Rounds
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
501-1,000
Company Stage
IPO
Headquarters
Rockville, MD
Founded
2005
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs